3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
9
Neoplasms
7
Anxiety Disorders
6
Depression
3
Ovarian Neoplasms
2
Chronic Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Tendinopathy
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sarcoma
1
Radiculopathy
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pathophobia
1
Pain, Postoperative
1
Pain
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Nausea
1
Myocarditis
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Lung Diseases, Interstitial
1
Leukemia, Myeloid, Acute
1
Hot Flashes
1
Interventions
Oxaliplatin
18
Surveys and Questionnaires
15
Fluorouracil
15
Capecitabine
13
Leucovorin
12
Blood Specimen Collection
11
Irinotecan
10
Standard of Care
7
Cisplatin
7
Endoscopic Mucosal Resection
6
atezolizumab
5
Specimen Handling
5
Radiotherapy
5
Educational Status
5
Drug Therapy
5
Docetaxel
5
S 1 (combination)
4
Radiosurgery
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Interviews as Topic
4
Gemcitabine
4
Everolimus
4
Colonoscopy
4
Biopsy
4
Bevacizumab
4
tegafur-gimeracil-oteracil
3
pemigatinib
3
apatinib
3
Remote Patient Monitoring
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gastrointestinal Neoplasms
×
Hypnosis
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled